Clinical Effectiveness and Impact on Insulin Therapy Cost After Addition of Dapagliflozin to Patients with Uncontrolled Type 2 Diabetes
Crossref DOI link: https://doi.org/10.1007/s13300-016-0204-9
Published Online: 2016-10-19
Published Print: 2016-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Sosale, Bhavana
Sosale, Aravind
Bhattacharyya, Arpandev
Funding for this research was provided by:
None
Text and Data Mining valid from 2016-10-19
Article History
Received: 23 August 2016
First Online: 19 October 2016